Publications by authors named "Toshitaka Yuza"

Claim this Profile
E
Erythropoiesis stimulating agents are associated with serum fibroblast growth factor 23 metabolism in patients on hemodialysis.
Hirokazu Honda, Kenji Tanaka, Tetsuo Michihata, Keigo Shibagaki, Toshitaka Yuza

Clin Kidney J· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Impacts of Intravenous Iron Administration and Iron-Containing Phosphate Binders on Serum Intact Fibroblast Growth Factor 23 Levels.
Hirokazu Honda, Kenji Tanaka, Tetsuo Michihata, Keigo Shibagaki, Toshitaka Yuza

Blood Purif· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
Hirokazu Honda, Yasuna Kobayashi, Shoko Onuma, Keigo Shibagaki, Toshitaka Yuza

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Long-Term Erythropoiesis-Stimulating Agents on Iron Metabolism in Patients on Hemodialysis.
Shoko Onuma, Hirokazu Honda, Yasuna Kobayashi, Toshinori Yamamoto, Tetsuo Michihata, Toshitaka Yuza

Ther Apher Dial· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis